These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32434753)

  • 21. Paying for express checkout: competition and price discrimination in multi-server queuing systems.
    Deck C; Kimbrough EO; Mongrain S
    PLoS One; 2014; 9(3):e92070. PubMed ID: 24667809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembled Products: The Key to More Effective Competition And Antitrust Oversight in Health Care.
    Sage WM
    Cornell Law Rev; 2016; 101(3):609-700. PubMed ID: 27062731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Price comparison of high-cost originator medicines in European countries.
    Vogler S; Zimmermann N; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promise of biomedical innovation.
    Weil AR
    Health Aff (Millwood); 2015 Feb; 34(2):198. PubMed ID: 25646097
    [No Abstract]   [Full Text] [Related]  

  • 25. Reference pricing and price negotiations for innovative new drugs : viable policies in the long term?
    Gandjour A
    Pharmacoeconomics; 2013 Jan; 31(1):11-4. PubMed ID: 23329589
    [No Abstract]   [Full Text] [Related]  

  • 26. Too few drugs, too many poppies.
    Smith R
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):38-9. PubMed ID: 6797634
    [No Abstract]   [Full Text] [Related]  

  • 27. Measuring the Value of Pharmaceuticals in the US Health System.
    Walton SM; Basu A; Mullahy J; Hong S; Schumock GT
    Pharmacoeconomics; 2017 Jan; 35(1):1-4. PubMed ID: 27785770
    [No Abstract]   [Full Text] [Related]  

  • 28. Group Purchasing Organizations, Health Care Costs, and Drug Shortages.
    Bruhn WE; Fracica EA; Makary MA
    JAMA; 2018 Nov; 320(18):1859-1860. PubMed ID: 30347037
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical Cost Savings in the Intensive Care Unit.
    Pennell BT; Murphy CV; Byrd C; Tubbs C
    Crit Care Nurs Q; 2017; 40(4):414-423. PubMed ID: 28834862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand.
    Gleeson D; Lopert R; Reid P
    Health Policy; 2013 Oct; 112(3):227-33. PubMed ID: 23992756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The estimated impact of drug importation, mandatory mail service, and Medicaid fee reduction on community pharmacies in Michigan.
    McKercher PL
    J Manag Care Pharm; 2006 Mar; 12(2):157-63. PubMed ID: 16515374
    [No Abstract]   [Full Text] [Related]  

  • 32. An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?
    Hertzman P; Miller P; Tolley K
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):5-12. PubMed ID: 29186996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dogmatic slumbers: American business and health policy.
    Brown LD
    J Health Polit Policy Law; 1993; 18(2):339-57. PubMed ID: 8360453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 35. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmaceuticals: drug importation.
    Seay M; Jones TM
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-15. PubMed ID: 17361466
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-35. PubMed ID: 22423396
    [No Abstract]   [Full Text] [Related]  

  • 38. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost of pharmacological care of the elderly: implications for healthcare resources.
    O'Neill C; Hughes CM; Jamison J; Schweizer A
    Drugs Aging; 2003; 20(4):253-61. PubMed ID: 12641481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dormant Commerce Clause--Extraterritoriality Doctrine--Fourth Circuit Invalidates Maryland Statute Regulating Price Gouging in the Sale Of Generic Drugs.--Association for Accessible Medicines v. Frosh, 887 F.3d 664 (4th Cir. 2018).
    Harv Law Rev; 2019 Apr; 132(6):1748-55. PubMed ID: 30995706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.